Written on 26 October 2017. Posted in Presse- & Adhoc-Mitteilungen.

Heidelberg Pharma AG: Partner RedHill erhält Orphan Drug-Status für MESUPRON

• PDF File: images/files/presse-adhoc-mitteilungen/2022/6373f9d3b336c_20171026_Heidelberg-Pharma_PM_Redhill_MESUPRON_OrphanDrug-Status_dt_final_1.pdf

2017

• Created on 15 November 2022.
• Last updated on 15 November 2022.
• Hits: 1910